Genzyme Corporation - Product Pipeline Review - 2016

  • ID: 3635608
  • Company Profile
  • 74 pages
  • Global Markets Direct
  • Genzyme Corporation
1 of 4
Genzyme Corporation - Product Pipeline Review - 2016

Summary

The report ‘Genzyme Corporation - Product Pipeline Review - 2016’, provides an overview of the Genzyme Corporation’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Genzyme Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Genzyme Corporation
- The report provides overview of Genzyme Corporation including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Genzyme Corporation’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Genzyme Corporation’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Genzyme Corporation’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Genzyme Corporation
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Genzyme Corporation’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Genzyme Corporation Snapshot

Genzyme Corporation Overview

Key Information

Key Facts

Genzyme Corporation - Research and Development Overview

Key Therapeutic Areas

Genzyme Corporation - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Genzyme Corporation - Pipeline Products Glance

Genzyme Corporation - Late Stage Pipeline Products

Phase III Products/Combination Treatment Modalities

Genzyme Corporation - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Genzyme Corporation - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Genzyme Corporation - Drug Profiles

patisiran

Product Description

Mechanism of Action

R&D Progress

revusiran

Product Description

Mechanism of Action

R&D Progress

sargramostim

Product Description

Mechanism of Action

R&D Progress

vandetanib

Product Description

Mechanism of Action

R&D Progress

GZ-402666

Product Description

Mechanism of Action

R&D Progress

olipudase alfa

Product Description

Mechanism of Action

R&D Progress

ibiglustat

Product Description

Mechanism of Action

R&D Progress

GZ-402668

Product Description

Mechanism of Action

R&D Progress

VYAADC-01

Product Description

Mechanism of Action

R&D Progress

1D-11

Product Description

Mechanism of Action

R&D Progress

Gene Therapy to Activate SMN1 for Spinal Muscular Atrophy

Product Description

Mechanism of Action

R&D Progress

GENZ-644442

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Malaria

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit PMP22 for Charcot-Marie-Tooth Type 1 A

Product Description

Mechanism of Action

R&D Progress

Genzyme Corporation - Pipeline Analysis

Genzyme Corporation - Pipeline Products by Target

Genzyme Corporation - Pipeline Products by Route of Administration

Genzyme Corporation - Pipeline Products by Molecule Type

Genzyme Corporation - Pipeline Products by Mechanism of Action

Genzyme Corporation - Recent Pipeline Updates

Genzyme Corporation - Dormant Projects

Genzyme Corporation - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

GZ-402674

GZ-404477

tasidotin hydrochloride

teriflunomide

tolevamer potassium sodium

vandetanib

Genzyme Corporation - Locations and Subsidiaries

Head Office

Other Locations & Subsidiaries

Genzyme Corporation - Key Manufacturing Facilities

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Genzyme Corporation, Key Information

Genzyme Corporation, Key Facts

Genzyme Corporation - Pipeline by Indication, 2016

Genzyme Corporation - Pipeline by Stage of Development, 2016

Genzyme Corporation - Monotherapy Products in Pipeline, 2016

Genzyme Corporation - Partnered Products in Pipeline, 2016

Genzyme Corporation - Partnered Products/ Combination Treatment Modalities, 2016

Genzyme Corporation - Phase III, 2016

Genzyme Corporation - Phase II, 2016

Genzyme Corporation - Phase I, 2016

Genzyme Corporation - Preclinical, 2016

Genzyme Corporation - Discovery, 2016

Genzyme Corporation - Pipeline by Target, 2016

Genzyme Corporation - Pipeline by Route of Administration, 2016

Genzyme Corporation - Pipeline by Molecule Type, 2016

Genzyme Corporation - Pipeline Products by Mechanism of Action, 2016

Genzyme Corporation - Recent Pipeline Updates, 2016

Genzyme Corporation - Dormant Developmental Projects,2016

Genzyme Corporation - Discontinued Pipeline Products, 2016

Genzyme Corporation, Other Locations

Genzyme Corporation, Subsidiaries

Genzyme Corporation, Key Manufacturing Facilities

List of Figures

Genzyme Corporation - Pipeline by Top 10 Indication, 2016

Genzyme Corporation - Pipeline by Stage of Development, 2016

Genzyme Corporation - Monotherapy Products in Pipeline, 2016

Genzyme Corporation - Partnered Products in Pipeline, 2016

Genzyme Corporation - Pipeline by Top 10 Target, 2016

Genzyme Corporation - Pipeline by Route of Administration, 2016

Genzyme Corporation - Pipeline by Molecule Type, 2016

Genzyme Corporation - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll